Related Experiment Videos
Allograft rejection after lung transplantation.
Timothy P M Whelan1, Marshall I Hertz
1Division of Pulmonary, Allergy, and Critical Care Medicine, University of Minnesota, Minneapolis, MN 55455, USA. whela011@umn.edu
Clinics in Chest Medicine
|November 3, 2005
Summary
Lung transplantation is a vital therapy for advanced lung disease. This review covers the clinical presentation, treatment, and prevention of lung transplant rejection, a major limitation to success.
Area of Science:
- Medicine
- Immunology
- Thoracic Surgery
Background:
- Lung transplantation is an established treatment for end-stage lung disease.
- Organ rejection remains a significant challenge impacting long-term graft survival.
- Understanding rejection mechanisms is crucial for improving patient outcomes.
Purpose of the Study:
- To review the clinical manifestations of lung transplant rejection.
- To outline current treatment strategies for various rejection types.
- To discuss preventative measures against hyperacute, acute, and chronic rejection.
Main Methods:
- Literature review of clinical presentations.
- Analysis of treatment protocols for lung transplant rejection.
- Synthesis of prevention strategies based on current evidence.
Main Results:
- Rejection presents clinically with diverse symptoms.
- Timely intervention with immunosuppression is key to managing acute rejection.
- Chronic rejection poses a progressive threat requiring long-term management.
Conclusions:
- Effective management of lung transplant rejection involves early diagnosis and tailored treatment.
- Prevention strategies are essential to minimize the incidence and severity of rejection.
- Continued research is needed to overcome rejection and enhance lung allograft longevity.